**Core Concept**
In patients with liver disease, the choice of muscle relaxant is crucial due to the potential for drug accumulation and increased toxicity. The liver plays a significant role in metabolizing many drugs, including neuromuscular blockers.

**Why the Correct Answer is Right**
The correct answer is Rocuronium because it is primarily metabolized by the liver and has a shorter duration of action. This allows for rapid recovery and reduced accumulation in patients with liver disease. Rocuronium also has a lower risk of histamine release compared to other non-depolarizing muscle relaxants.

**Why Each Wrong Option is Incorrect**
**Option A:** Vecuronium is also metabolized by the liver, but it has a longer duration of action than Rocuronium, making it less ideal for patients with liver disease.
**Option B:** Succinylcholine is primarily metabolized by plasma cholinesterase and has a shorter duration of action, but it can cause hyperkalemia in patients with liver disease due to its effects on muscle membrane stability.
**Option C:** Atracurium is metabolized by ester hydrolysis and Hofmann elimination, which is independent of liver function, making it a safer choice for patients with liver disease. However, it has a longer duration of action and can cause histamine release.

**Clinical Pearl / High-Yield Fact**
When choosing a muscle relaxant in patients with liver disease, consider the drug's metabolism and duration of action. Rapid recovery and reduced accumulation are crucial in these patients.

**Correct Answer: C. Atracurium**